/BIOX

BIOX Stock - Bioceres Crop Solutions Corp.

Q: What is the analyst price target for BIOX?

Analyst price target information is not currently available for BIOX.

Q: What is BIOX's market cap?

Market capitalization information is not currently available for BIOX.

Basic Materials|Agricultural Inputs|NASDAQ

$1.40+0.72%

+$0.01 (+0.72%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+197.9%upside

Target: $4.17

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BIOX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.45

52W High$7.44

52W Low$1.20

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$333.30M	$464.83M	$419.45M	$328.46M	$206.70M
Gross Profit	$130.20M	$181.59M	$180.25M	$126.44M	$90.88M
Gross Margin	39.1%	39.1%	43.0%	38.5%	44.0%
Operating Income	$-3,700,000	$44.82M	$54.18M	$39.87M	$38.38M
Net Income	$-51,800,000	$3.24M	$18.78M	$-7,199,618	$-6,870,163
Net Margin	-15.5%	0.7%	4.5%	-2.2%	-3.3%
EPS	$-0.82	$0.05	$0.30	$-0.17	$-0.18

Company Overview

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

80%

Hold / Neutral

20%

Sell / Underperform

Analyst Consensus🟢 Bullish

4 Bullish1 Neutral/Bearish

Price Targets

$14

Average Target

↑ 928.6% Upside

Now

Low

$14

Average

$23

High

Based on 5 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
October 22nd 2025	Oppenheimer	Downgrade	Perform	-
September 10th 2025	Canaccord Genuity	Downgrade	Hold	$2.5
July 19th 2024	Canaccord Genuity	Resumed	Buy	$17
July 2nd 2024	ROTH MKM	Resumed	Buy	$15
April 6th 2023	Oppenheimer	Initiation	Outperform	$15
September 30th 2022	Canaccord Genuity	Initiation	Buy	$22.5

Earnings History & Surprises

BIOX

Beat Rate

25%

Last 16 quarters

Avg Surprise

-18.2%

EPS vs Estimate

Beats / Misses

4/12

Last 12 quarters

Latest EPS

$-0.12

Q4 2025

EPS Surprise History

Q4 23

-216.7%

$-0.07vs$0.06

Q1 24

-77.8%

$0.02vs$0.09

Q2 24

-17.6%

$0.14vs$0.17

Q4 24

No data

Q4 24

-800.0%

$-0.09vs$-0.01

Q1 25

-92.9%

$0.01vs$0.14

Q2 25

+80.0%

$-0.02vs$-0.10

Q4 25

-200.0%

$-0.12vs$-0.04

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 10, 2026	$0.07	—	—	—
Q4 2025	Nov 12, 2025	$-0.04	$-0.12	-200.0%	✗ MISS
Q2 2025	May 21, 2025	$-0.10	$-0.02	+80.0%	✓ BEAT
Q1 2025	Feb 11, 2025	$0.14	$0.01	-92.9%	✗ MISS
Q4 2024	Nov 11, 2024	$-0.01	$-0.09	-800.0%	✗ MISS
Q4 2024	Oct 25, 2024	—	$-0.03	—	—
Q2 2024	May 29, 2024	$0.17	$0.14	-17.6%	✗ MISS
Q1 2024	Feb 8, 2024	$0.09	$0.02	-77.8%	✗ MISS
Q4 2023	Nov 13, 2023	$0.06	$-0.07	-216.7%	✗ MISS
Q3 2023	Sep 11, 2023	$0.05	$-0.06	-220.0%	✗ MISS
Q2 2023	May 10, 2023	$0.02	$0.44	+1792.5%	✓ BEAT
Q1 2023	Feb 8, 2023	$0.07	$-0.13	-285.7%	✗ MISS
Q4 2022	Nov 29, 2022	$0.05	$0.01	-80.0%	✗ MISS
Q2 2022	Jun 30, 2022	—	$-0.11	—	—
Q2 2022	May 27, 2022	$-0.08	$-0.16	-100.0%	✗ MISS
Q1 2022	Feb 25, 2022	$0.05	$0.08	+60.0%	✓ BEAT
Q4 2021	Nov 30, 2021	$0.09	$0.02	-77.8%	✗ MISS
Q2 2021	Jun 30, 2021	—	$0.02	—	—
Q2 2021	May 28, 2021	$-0.05	$-0.03	+40.0%	✓ BEAT
Q1 2021	Feb 26, 2021	$0.36	$0.02	-94.4%	✗ MISS

Frequently Asked Questions about BIOX

What is BIOX's current stock price?

Bioceres Crop Solutions Corp. (BIOX) is currently trading at $1.40 per share. The stock has moved +0.72% today.

What is the analyst price target for BIOX?

The average analyst price target for BIOX is $4.17, based on 1 analyst.

What sector is Bioceres Crop Solutions Corp. in?

Bioceres Crop Solutions Corp. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the NASDAQ exchange.

What is BIOX's market cap?

Bioceres Crop Solutions Corp. has a market capitalization of $0.09 billion, making it a small-cap company.

Does BIOX pay dividends?

No, Bioceres Crop Solutions Corp. does not currently pay a dividend to shareholders.